MARFIA, GIROLAMA ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 45.446
EU - Europa 8.771
AS - Asia 6.443
SA - Sud America 970
AF - Africa 64
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 13
Totale 61.726
Nazione #
US - Stati Uniti d'America 45.296
IT - Italia 5.208
SG - Singapore 3.499
CN - Cina 900
BR - Brasile 827
HK - Hong Kong 690
KR - Corea 677
DE - Germania 622
IE - Irlanda 603
UA - Ucraina 536
RU - Federazione Russa 359
GB - Regno Unito 304
FR - Francia 249
VN - Vietnam 222
SE - Svezia 217
NL - Olanda 171
FI - Finlandia 157
IN - India 102
PL - Polonia 102
CA - Canada 88
JP - Giappone 67
AR - Argentina 53
AT - Austria 51
CH - Svizzera 42
MX - Messico 39
BD - Bangladesh 38
TR - Turchia 37
ES - Italia 35
ID - Indonesia 35
IQ - Iraq 31
ZA - Sudafrica 26
BE - Belgio 25
RO - Romania 24
IR - Iran 21
EC - Ecuador 20
CL - Cile 19
UZ - Uzbekistan 18
CZ - Repubblica Ceca 15
EG - Egitto 13
PY - Paraguay 13
EU - Europa 12
AU - Australia 11
CO - Colombia 11
GR - Grecia 11
KG - Kirghizistan 11
PH - Filippine 11
MA - Marocco 10
MY - Malesia 10
PE - Perù 10
SA - Arabia Saudita 10
HR - Croazia 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
KE - Kenya 8
PK - Pakistan 8
UY - Uruguay 7
AZ - Azerbaigian 6
TT - Trinidad e Tobago 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AL - Albania 5
DO - Repubblica Dominicana 5
IL - Israele 5
NO - Norvegia 5
NP - Nepal 5
DZ - Algeria 4
JO - Giordania 4
LT - Lituania 4
TW - Taiwan 4
BG - Bulgaria 3
DK - Danimarca 3
GE - Georgia 3
OM - Oman 3
TH - Thailandia 3
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
JM - Giamaica 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
NI - Nicaragua 2
PA - Panama 2
QA - Qatar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BS - Bahamas 1
BY - Bielorussia 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
HN - Honduras 1
HU - Ungheria 1
LK - Sri Lanka 1
LV - Lettonia 1
NR - Nauru 1
NZ - Nuova Zelanda 1
Totale 61.720
Città #
Wilmington 12.528
Houston 11.466
Woodbridge 11.457
Singapore 1.311
Fairfield 1.149
Chandler 859
Ann Arbor 797
Hong Kong 686
Ashburn 627
Rome 608
Dublin 551
Seattle 451
Cambridge 429
Milan 428
Beijing 400
Medford 373
Jacksonville 363
New York 358
Dearborn 318
Santa Clara 277
Los Angeles 183
Lawrence 175
Dallas 160
The Dalles 157
Buffalo 121
Bologna 117
Turin 95
Ho Chi Minh City 89
Naples 82
Torino 81
Zhengzhou 81
São Paulo 80
Verona 78
San Diego 77
Moscow 71
Kraków 67
Florence 57
Council Bluffs 53
Creede 53
Redondo Beach 51
Padova 48
Redwood City 48
Nuremberg 45
Munich 44
Norwalk 44
Mülheim 43
Hanoi 42
London 42
Menlo Park 42
Chicago 40
Trento 39
San Jose 38
Palo Alto 35
Piove di Sacco 35
Roebling 35
North Bergen 32
Seoul 32
Bari 31
Brescia 31
Genoa 31
Palermo 31
Tokyo 31
Atlanta 28
Lappeenranta 28
Helsinki 27
Jakarta 26
Pavia 26
Warsaw 24
Bergamo 23
Brussels 23
Salt Lake City 23
Toronto 23
Brooklyn 22
Cagliari 22
Guangzhou 22
Belo Horizonte 21
Boardman 21
Mcallen 21
Nanjing 21
Parma 20
San Francisco 20
Shanghai 20
Stockholm 20
Catania 19
Falls Church 19
Hefei 19
Mountain View 19
Ottawa 19
Phoenix 19
Rimini 19
Rio de Janeiro 19
Elk Grove Village 18
Kunming 18
Perugia 18
Brasília 17
Columbus 17
Lucca 17
Messina 17
Monza 17
Vienna 17
Totale 48.992
Nome #
Batteria per la valutazione del Deterioramento Mentale (parte II): standardizzazione e affidabilità diagnostica nell’identificazione di pazienti affetti da sindrome demenziale 2.373
Batteria per la valutazione del Deterioramento Mentale (parte I): descrizione di uno strumento di diagnosi neuropsicologica 2.373
Batteria per la valutazione del Deterioramento Mentale (parte III): analisi dei profili qualitativi di compromissione cognitiva 954
The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. 617
The impact of rotigotine on cardiovascular autonomic function in early Parkinson's disease. 571
Posterior cortical atrophy with unilateral occipito-temporal degeneration 552
Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy 549
Neurophysiology of synaptic functioning in multiple sclerosis 548
Explicit memory and repetition priming in dementia: evidence for a common basic mechanism underlying conscious and unconscious retrieval deficits 545
Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects 535
A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication 510
Lexical and conceptual components of stem completion priming in patients with Alzheimer's disease 500
No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML 494
Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes 492
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis 482
Subacute demyelinating polyneuropathy in B-cell lymphoma with IgM antibodies against glycolipid GD1b 479
Chronic dopaminergic treatment in restless legs syndrome: Does it affect the autonomic nervous system? 479
TRPV1 polymorphisms and risk of interferon β-induced flu-like syndrome in patients with relapsing-remitting multiple sclerosis 479
Brain MR diffusion tensor imaging in Kennedy's disease 478
Anti-sulfatide/galactocerebroside antibodies in immunoglobulin M paraproteinemic neuropathies 464
Abnormal cervical lymph nodes in multiple sclerosis: a preliminary ultrasound study 460
Percutaneous tibial nerve stimulation produces effects on brain activity: study on the modifications of the long latency somatosensory evoked potentials 457
Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability 449
Association of HLA-DQB1∗05:02 and DRB1∗16 Alleles with Late-Onset,Nonthymomatous, AChR-Ab-Positive Myasthenia Gravis 446
RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis 442
Synaptic transmission in the striatum: from plasticity to neurodegeneration 441
International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome 441
Acute disseminated encephalomyelitis following Campylobacter jejuni gastroenteritis: Case report and review of the literature 440
Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study 439
Central and peripheral nervous system involvement as a manifestation of graft versus host disease after liver transplantation: case report 438
Interleukin-8 is associated with acute and persistent dysfunction after optic neuritis 437
Sympathetic autonomic system is differentially altered in progressive and relapsing multiple sclerosis 434
Perceptual and conceptual components in implicit and explicit stem completion 431
IgM MGUS and Waldenstrom-associated anti-MAG neuropathies display similar response to rituximab therapy 426
Intestinal pseudobstruction as presenting event of fatal cerivastatin-induced myopathy 426
Acute demyelinating sensorimotor polyneuropathy in B-cell lymphoma with IGM autoantibodies against glycolipid GD1B 424
Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease 421
Inverse correlation between VEGF and soluble VEGF receptor 2 in POEMS with AIDP responsive to intravenous immunoglobulin 421
Italian multicentre study of peroneal mononeuropathy: multiperspective follow-up 420
Fingolimod reduces the clinical expression of active demyelinating lesions in MS 418
Electrophysiological recordings and calcium measurements in striatal large aspiny interneurons in response to combined O2/glucose deprivation 416
EPIDEMIOLOGY AND POTENTIAL PROGNOSTIC FACTORS IN GUILLAIN-BARRE SYNDROME: TEN-YEAR EXPERIENCE OF "POLICLINICO TOR VERGATA" 415
IS DN4 AS A SCREENING TOOL FOR NEUROPATHIC PAIN SUITABLE FOR PAINFUL DIABETIC POLYNEUROPATHY? 414
An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons 412
Clinical correlates of painful diabetic neuropathy and relationship of neuropathic pain with sensorimotor and autonomic nerve function 410
A multicentric cohort study on anti-mag antibodies neuropathy: does response to rituximab differ depending on the associated hematological disease? 410
Ionic mechanisms underlying differential vulnerability to ischemia in striatal neurons 409
Bickerstaff encephalitis with anti gm1-antibodies relapsing as guillain-barre syndrome: a case report 409
Nerve growth factor is elevated in the CSF of patients with multiple sclerosis and central neuropathic pain 408
Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability 407
The autonomic balance predicts cardiac responses after the first dose of fingolimod 406
A Novel Association Between Nondipping and Painful Diabetic Polyneuropathy 405
INSULIN AUTOIMMUNE SYNDROME (HIRATA DISEASE) RELATED TO THE ALPHA-LIPOIC ACID ASSUMPTION: CASE REPORT AND REVIEW OF THE LITERATURE 405
Repetitive transcranial magnetic stimulation of the motor cortex ameliorates spasticity in multiple sclerosis 398
Recency effect in anterograde amnesia: evidence for distinct memory stores underlying enhanced retrieval of terminal items in immediate and delayed recall paradigms 398
Validation of the nerve axon reflex for the assessment of small nerve fibre dysfunction 393
Diabetic peripheral neuropathic pain is a stronger predictor of depression than other diabetic complications and comorbidities 393
Bickerstaff encephalitis: report of two atypical cases with negative anti GQ1B antibodies 391
Sensory profiles of neuropathic pain in painful diabetic polyneuropathy 390
Glutamate-triggered events inducing corticostriatal long-term depression 387
Heidenhain variant in two patients with inherited V210I Creutzfeldt-Jakob disease 387
Sensory profiles of neuropathic pain in painful diabetic polyneuropathy 387
Prevalence and characteristics of neuropathic pain in painful diabetic polyneuropathy 387
Long latency somatosensory evoked potentials: Modifications after percutaneous tibial nerve stimulation 385
Is autonomic nervous system involved in restless legs syndrome during wakefulness? 385
Activation of metabotropic glutamate receptor subtype 1/protein kinase C/mitogen-activated protein kinase pathway is required for postischemic long-term potentiation in the striatum 383
Electrophysiology of the neuroprotective agent riluzole on striatal spiny neurons 377
High sensitivity of autonomic function tests in a case of food-borne botulism 376
Is autonomic nervous system involved in restless legs syndrome during wakefulness? 376
The neuroprotective agent BW619C89 inhibits neuronal excitability and synaptic transmission in rat corticostriatal slices 373
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study) 371
Neuropathic pain impact on sleep and circadian rhythm of blood pressure in painful diabetic polyneuropathy 370
Subclinical autonomic dysfunction in spinobulbar muscular atrophy (Kennedy disease) 369
Meningomyeloradiculitis mimicking recurrent bilateral neuralgic amyotrophy. 367
Il deterioramento cognitivo nel paziente cerebroleso 367
Does continuous positive airway pressure treatment affect autonomic nervous system in patients with severe obstructive sleep apnea? 365
Pharmacological inhibition of the Na(+)/Ca(2+) exchanger enhances depolarizations induced by oxygen/glucose deprivation but not responses to excitatory amino acids in rat striatal neurons 364
Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: results from a double-blind, randomised, multicentre, long-term, placebo-controlled clinical trial 364
Autonomic nervous system involvement in patients with chronic dysimmune neuropathies 361
Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory 358
A multicentric cohort study on anti-mag antibodies neuropathy: does response to rituximab differ depending on the associated hematological disease? 358
Neuropatie disimmuni 355
Il priming di ripetizione nel deterioramento cognitivo: ipotesi sull’organizzazione della funzione mnesica 349
Validity of DN4 as a screening tool for neuropathic pain of painful diabetic polyneuropathy 349
Remodeling functional connectivity in multiple sclerosis: A challenging therapeutic approach 348
Modulation of gene expression following long-term synaptic depression in the striatum 347
Glutamate-triggered events inducing corticostriatal LTD 345
Effects of motor cortex rTMS on lower urinary tract dysfunction in multiple sclerosis 343
Relapsing aidp responsive to intravenous immunoglobulin in poems syndrome 341
AN ITALIAN MULTICENTER DATABASE FOR THE DIAGNOSIS AND THERAPY OF CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY (CIDP) AND ITS VARIANTS: DATA FROM THE FIRST 300 PATIENTS 340
Efficacy of intravenous immunoglobulin in poems-related relapsing AIDP 339
Corticobulbar And Corticospinal Tract Involvement In Kennedy's Disease 338
Long latency somatosensory evoked potentials: Changes after percutaneous tibial nerve stimulation 336
Myotonic dystrophy unlinked to DM1 and DM2 mutations in three siblings 335
High dose intravenous immunoglobulin is effective in painful diabetic polyneuropathy resistant to conventional treatments: results of a double blind, randomized, placebo-controlled, multicenter trial 334
Motor unit number estimation in 30 patients with chronic dysimmune neuropathies 332
Dimethyl fumarate vs. fingolimod in multiple sclerosis: an independent, multi-centre, real world, quasi-randomized study 332
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 332
Nondipping is a novel associated disorder of painful diabetic polyneuropathy 331
Prevalence of anti-neurofascin-155 and anti-contactin-1 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: a serological multicenter study in Italy 330
Totale 45.547
Categoria #
all - tutte 157.299
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 157.299


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.995 0 0 0 0 0 958 1.168 880 281 224 354 130
2021/20222.205 142 164 118 187 145 209 132 131 146 183 131 517
2022/20233.355 266 183 299 380 241 610 422 220 278 90 257 109
2023/20241.776 178 62 127 166 143 224 142 127 107 121 89 290
2024/20256.621 228 1.097 632 416 240 486 438 260 631 608 845 740
2025/20264.145 738 461 1.081 644 931 290 0 0 0 0 0 0
Totale 62.727